![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 3, 1839-1845, January 21, 2000
From the Department of Biochemistry, Weill Medical College of
Cornell University, New York, New York, 10021
The gp41 envelope protein mediates entry of human
immunodeficiency virus type 1 (HIV-1) into the cell by promoting
membrane fusion. The crystal structure of a gp41 ectodomain core in its fusion-active state is a six-helix bundle in which a N-terminal trimeric coiled coil is surrounded by three C-terminal outer helices in
an antiparallel orientation. Here we demonstrate that the N34(L6)C28 model of the gp41 core is stabilized by interaction with the ionic detergent sodium dodecyl sulfate (SDS) or the nonionic detergent n-octyl- Enveloped viruses enter cells by a viral envelope protein-promoted
membrane fusion process that mediates penetration of the viral genome
into host cells. The mechanism of viral membrane fusion is best
understood for the hemagglutinin
(HA)1 protein of influenza
virus. The labile native (nonfusogenic) structure of HA is transformed,
in a "spring-loaded" manner, by acidic pH to an energetically more
stable, fusion-active (fusogenic) conformation (1-7). This
conformational change leads to insertion of the hydrophobic fusion
domain termed fusion peptide at the N terminus of the transmembrane
subunit HA2 into the target membrane and ultimately results
in fusion of the viral and celluar membranes and infection of the cell
(1, 2, 5-9).
The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein
mediates the early binding and entry steps in viral infection. The
envelope glycoprotein consists of a complex of the surface subunit
gp120 and the transmembrane subunit gp41 (10, 11). gp120 determines
viral tropism by binding to both CD4 and one of several chemokine
coreceptor molecules at the T-cell surface (Refs. 12 and 13; see also
Ref. 14). These protein-protein interactions induce structural changes
in the envelope protein and exposure of the hydrophobic fusion peptide
of the gp41 subunit, which then mediates fusion of the apposed virus
and cell membranes. Significant advances have been made in recent years
in elucidating the molecular basis of gp41-mediated membrane fusion
(reviewed in Ref. 15). Protein dissection studies revealed that two 4,3 hydrophobic (heptad) repeat regions within the gp41 ectodomain form a
soluble, The structure of the gp41 core resembles the proposed fusion-active
conformations of the transmembrane envelope proteins from influenza
virus and Moloney murine leukemia virus (2, 19-21, 26). The core of
each of the three structures consists of a trimeric coiled coil
adjacent to the N-terminal fusion peptide, with three The surface of the gp41 core is highly grooved and possesses distinct
hydrophilic and hydrophobic regions, features that may be essential for
the binding of lipid membranes. Here we show that the N34(L6)C28 model
of the gp41 core is stabilized by interaction with the anionic
detergent sodium dodecyl sulfate (SDS) or the nonionic detergent
n-octyl- Protein Production--
The recombinant N34(L6)C28 model was
expressed in Escherichia coli BL21(DE3)/pLysS using the T7
expression system (30) and purified to homogeneity by reverse-phase
high performance liquid chromatography (HPLC) as described previously
(17). Protein identity was confirmed by mass spectrometry. Protein
concentrations were determined by absorbance at 280 nm in 6 M guanidinium hydrochloride, with an extinction coefficient
calculated based on tryptophan and tyrosine (31).
Circular Dichroism Spectroscopy--
CD spectra were acquired in
50 mM sodium phosphate, pH 7.0, and 150 mM
sodium chloride (PBS) with an Aviv 62 DS spectrometer as described
previously (32). The same buffer was also used to prepare micellar
solutions of Equilibrium Ultracentrifugation--
Sedimentation equilibrium
analysis was performed on a Beckman XL-A analytical ultracentrifuge as
described previously (32). Protein solutions were dialyzed overnight
against PBS containing SDS or Vesicle Preparation--
Small unilamellar vesicles of
dimyristoylphosphatidylglycerol (DMPG) (Sigma) and 1-palmitoyl,
1,2-oleyl phosphatidylcholine (POPE) (Avanti Polar Lipids, Birmingham,
AL) were prepared by nitrogen stream evaporation of a 5 mg/ml
chloroform solution of the lipid followed by redispersion in PBS (pH
7.0) and sonication in a bath sonicator at 4 °C for 45 min.
Crystallization and Data Collection--
N34(L6)C28 was
crystallized at room temperature by vapor diffusion. A stock of
HPLC-purified N34(L6)C28 was dissolved in water, and its final protein
concentration was adjusted to 10 mg/ml. Initial crystallization
conditions were found by using the hanging-droplet method with sparse
matrix crystallization kits (Crystal Screen I and II, Hampton Research,
Riverside, CA) and then optimized. Centered cubic crystals with the
symmetry of space group I213 were obtained from 0.1 M sodium HEPES, pH 7.5, 0.8 M potassium sodium
tartrate, and 10 mM SDS. Data to 2.7 Å resolution on the cubic crystals were collected at room temperature at the X-ray Crystallography Facility at the Weill Medical College of Cornell University using an R-axis IV image plate detector mounted
on a Rigaku RU200 rotating anode x-ray generator. Primitive
rhombohedral crystals with the symmetry of space group R3 were obtained
from 0.1 M sodium citrate, pH 5.6, 1.0 M
ammonium dihydrogen phosphate, and 35 mM Structure Determination and Refinement--
The structures of
N34(L6)C28 crystallized in the presence of detergent were determined by
molecular replacement by using the program AMoRe (37). The 2.4 Å structure of N34(L6)C28 (Protein Data Bank code 1STZ) was used in a
combined rotation-translation search (using 8.0-3.5 Å data) to yield
a solution for N34(L6)C28/SDS (correlation coefficient, 60.9%;
R-factor, 45.1%). Density interpretation and model building
were done with the program O (38). Crystallographic refinement of the
structure was done with the program X-PLOR (39). Prior to refinement,
5% of the diffraction data were set aside for cross-validation (free
R-factor calculation). Noncrystallographic symmetry
restraints were not used in the final refinement. Despite the
relatively high mean B-factor 42 Å2, the model
is generally well defined in the electron density (see Fig.
5A). The final refined model (Rcryst = 18.3%; Rfree = 31.5%) includes 162 of 204 residues in the N34(L6)C28 trimer. No ordered density was observed for
SDS. The following regions do not have clear electron density and are
presumed to be disordered: residues 546-550 and 653-655 of gp41 and
the linker region. All
Cross-rotation and cross-translation functions (using 10.0-3.0 Å data) by using the 2.4 Å structure of N34(L6)C28 as a search model
yielded a solution for N34(L6)C28/ N34(L6)C28 Conformation in Detergent Micelles--
We have
previously shown that the recombinant N34(L6)C28 model of the HIV-1
gp41 core forms a six-helix-bundle structure in solution and in
crystals and shows a cooperative thermal unfolding transition (18, 21).
To analyze the conformation of N34(L6)C28 in the hydrophobic
environment of the lipid bilayer, we first characterized the
physicochemical properties of N34(L6)C28 in the presence of the ionic
detergent SDS. SDS micellar system (the critical micellar concentration
is 8.2 mM) has been widely used to study peptide-lipid and
protein-lipid interactions (42-48). On the basis of CD measurements at
a 10 µM protein concentration in PBS at 20 °C in the
presence of 2 and 10 mM SDS, N34(L6)C28 displays a ~75%
Taken together, these results indicate that N34(L6)C28 can form a
highly stable six-helix bundle in SDS micelles. The lower helicity of
N34(L6)C28 in the presence of SDS compared with PBS may be due to the
partially unfolded region in the molecule (see below). It is extremely
unusual for a small protein motif, in SDS solution that is in excess of
its critical micellar concentration, to fold into a stable structure
that is similar to that found under native conditions. By extension,
the six-helix bundle of the gp41 core likely interacts preferentially
with SDS micelles.
To determine the general feature of the gp41 core-detergent
interaction, we analyzed the conformation of N34(L6)C28 in N34(L6)C28 Conformation in Lipid Vesicles--
To further
investigate the gp41 core-membrane interaction, we examined the
conformation of N34(L6)C28 in DMPG and POPE bilayer vesicles, systems
that imitate more closely the structural features of physiologically
relevant bilayer membranes (e.g. 49, 50). CD measurements at
10 µM protein and 4 mM lipid concentrations
in PBS (pH 7.0) at 20 °C indicate that N34(L6)C28 folds into
Crystal Structures of N34(L6)C28 in Detergent Micelles--
To
evaluate the high resolution structural features of the gp41 core in
detergent micelles, we determined the x-ray structure of a new centered
cubic crystal form of N34(L6)C28 grown in the presence of 10 mM SDS at 2.7 Å resolution (see under "Experimental Procedures"). This crystal structure, designated N34(L6)C28/SDS, was
refined to a conventional R-factor of 18.3% with a free
R-factor of 31.5% and root mean square deviations from
ideal bond lengths and bond angles of 0.004 Å and 0.763°,
respectively (Table II). Moreover, we
determined the 1.45 Å resolution x-ray structure of primitive
rhombohedral crystals of N34(L6)C28 grown in 35 mM
The overall topologies of N34(L6)C28 crystallized from the detergent
media are the same as that of the molecule in water. In all cases,
three hairpin-like molecules pack together on the crystallographic
3-fold symmetry axis to form a six-helix bundle. Three N34 helices
within the bundle form a central, parallel trimeric coiled coil with a
left-handed superhelical pitch, whereas three C28 helices pack, in an
antiparallel orientation, into three hydrophobic grooves on the surface
of the N34 coiled coil (Fig.
6A). The root mean square
deviations between C
As was observed with the crystal structures of the gp41 core, the
N-terminal coiled-coil trimer surface is highly grooved and possesses
three conserved hydrophobic cavities that provide binding pockets for
three C-terminal helices (19-21, 53). The predominantly hydrophobic
interactions between the N- and C-terminal helices are the key
determinants of the six-helix bundle fold and may play a role in the
gp41 core-lipid interaction. A comparison of the hydrophobic cavity in
the N34(L6)C28 structures in water and detergent media reveals that the
two key residues (Trp-571 and Trp-631) involved in forming the cavity
show different rotamers (Fig. 7). Whereas
the side chains of the surface residues in the vicinity of the
conserved cavity deviate substantially in the three structures, the
interior core residues in the coiled-coil heptad positions have similar
packing geometries (Fig. 7). In all three structures, Thr 569 at a
d heptad position in the N34 coiled coil, for example, has
its hydroxyl group hydrogen-bonded to the carbonyl oxygen of Leu-565
and still uses its hydrophobic methyl group pointing toward the center
of the trimeric coiled coil. Although we cannot exclude the possibility
that the exterior side chain packing discrepancies among the three
structures of N34(L6)C28 may be due to differences in crystallization
media, crystal packing contacts, and the use of different crystal
forms, these surface residues are likely to be involved in the
six-helix bundle-lipid interaction. In addition, the SDS and Emerging structural and biochemical work reveals conservation of a
core structure between HIV-1 gp41 and the transmembrane subunits of the
influenza virus and Moloney murine leukemia virus envelope proteins (2,
19-21, 26). The core structure reveals a three-stranded, Numerous studies have led to the proposal that viral membrane fusion
proteins can exist in two major conformations: the native structure on
the surface of the virion is metastable and thus has the potential to
transform to a stable and fusogenic conformation during the membrane
fusion step of HIV-1 infection (1, 3, 4). The native state of the
influenza HA protein, for example, is trapped in a metastable
conformation that, upon destabilization, converts into an energetically
more stable and fusion-active structure (1, 3, 4, 55). This strategy
might well be shared by the HIV-1 envelope glycoprotein (4). Therefore,
understanding the factors that determine the conformational specificity
and stability of the native and fusogenic folds is required for
addressing essential structural and mechanistic questions about the
mechanism of viral entry into cells.
The native state of the HIV-1 envelope protein complex is also thought
to be metastable and readily undergoes a receptor-activated conformational change to a fusogenic structure (reviewed in Ref. 14).
Recent evidence indicates that the six-helix bundle structure of the
gp41 ectodomain core represents the fusogenic state of the HIV-1
envelope, similar to the low pH-induced conformation of influenza virus
HA (16, 19-25). This finding and the structural and biophysical
studies of the gp41 core (16-21) suggest that upon binding of gp120 to
CD4 and its subsequent interaction with a chemokine coreceptor, the
gp41 ectodomain orchestrates a complex series of protein-protein
interactions and structural changes that results in the colocalization
of the virus and cell membranes (20, 23, 27). According to this
suggestion, formation of the six-helix bundle structure brings the two
membranes into close proximity for membrane fusion because the
N-terminal fusion peptide region and the transmembrane helix of gp41
are embedded in the target cell and viral membranes, respectively.
Little is known about how this membrane apposition overcomes the energy
barrier for membrane fusion.
The current model for gp41-mediated membrane fusion suggests that the
six-helix bundle formation is intimately associated with the viral and
cellular membranes during the virus binding and fusion (15, 20, 23,
27). Biochemical evidence also suggests that more than just the
N-terminal fusion peptide region of gp41 can interact with the lipid
membrane (29). These considerations led us to surmise that the
fusion-active gp41 ectodomain core interacts with lipid bilayers. The
results described above indeed indicate that the six-helix bundle
structure is stabilized by interaction with SDS or We are grateful for Yu Luo for help with
calculating search models and crystallographic computation. We also
thank Malcolm Cupel of beamline X12B at the National Synchrotron Light
Source laboratories for support and Jennifer Poitras for secretarial help, Temple Burling for assistance with data collection, and Chris
Lima and Jun Dong for suggestions on structural refinement.
*
This work was supported by National Institutes of Health
Grant AI42382.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and structure factors (codes 1DF4 and
1DF5) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New
Brunswick, NJ (http://www.rcsb.org).
The abbreviations used are:
HA, hemagglutinin;
HIV-1, human immunodeficiency virus type 1;
SDS, sodium dodecyl
sulfate;
Interactions between HIV-1 gp41 Core and Detergents and Their
Implications for Membrane Fusion*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-glucopyranoside (
OG). The high
resolution x-ray structures of N34(L6)C28 crystallized from two
different detergent micellar media reveal a six-helix bundle
conformation very similar to that of the molecule in water. Moreover,
N34(L6)C28 adopts a highly
-helical conformation in lipid vesicles.
Taken together, these results suggest that the six-helix bundle of the
gp41 core displays substantial affinity for lipid bilayers rather than
unfolding in the membrane environment. This characteristic may be
important for formation of the fusion-active gp41 core structure and
close apposition of the viral and cellular membranes for fusion.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helical complex consisting of a trimer of antiparallel heterodimers (Fig. 1) (16-18). X-ray
crystallographic analyses confirmed that this gp41 core is a six-helix
bundle (19-21). Three N-terminal helices form a central,
three-stranded coiled coil, while three C-terminal helices pack in the
antiparallel manner into conserved hydrophobic grooves on the surface
of the coiled-coil trimer. On the basis of these findings and a number
of recent studies, it was proposed that this six-helix bundle structure represents the core of fusion-active gp41 (16, 19-24). Consistent with
this view, a monoclonal antibody specifically recognizing the gp41 core
binds to the surface of HIV-1 infected cells only after interaction of
the envelope protein complex with soluble CD4 (25).

View larger version (9K):
[in a new window]
Fig. 1.
HIV-1 gp41 core structure. A schematic
diagram of gp41 showing the important functional regions of the
ectodomain. The amino acid sequences of the N34 and C28 segments are
shown. The N34(L6)C28 model of the gp41 core consists of N34 and C28
plus a linker of six hydrophilic residues. The disulfide bond and four
potential N-glycosylation sites are depicted. The residues
are numbered according to their position in gp160.
-helices
packed in an antiparallel orientation against the coiled coil. This
conserved structure suggests a common theme for viral membrane fusion,
notably that formation of the helical-hairpin structure leads to
juxtaposition of the virus and cell membranes for fusion (20, 23, 27).
According to this theory, the helical-bundle molecule, a protein, is
required to break the energy barrier for fusion of two membranes, which
is energetically unfavorable. This model implies that the helical
structure interacts with lipid membranes. This notion is supported by
electron paramagnetic resonance spectroscopic experiments that indicate
that the coiled-coil region adjacent to the fusion peptide region of HA
interacts with lipid bilayers only in the fusion-active state (28).
Again, using electron paramagnetic resonance, a peptide corresponding
to the N-terminal heptad-repeat region within the gp41 ectodomain of HIV-1 shows membrane binding (29). These lipid-binding phenomena are
postulated to facilitate membrane fusion (28).
-D-glucopyranoside (
OG). The x-ray structures of N34(L6)C28 crystals grown from these detergent micellar media at resolutions of 2.7 (SDS) and 1.45 Å (
OG) reveal a
six-helix bundle conformation that is very similar to that of the
molecule in water. Moreover, N34(L6)C28 folds into a fully helical
conformation in lipid vesicles. Our results suggest that the six-helix
bundle structure can interact with lipid bilayers. This membrane
binding may play a role in facilitating both the gp41 conformational
change during fusion activation and local apposition of the viral and cellular membranes for fusion.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
OG and SDS. The wavelength dependence of molar
ellipticity, [
], was monitored at 20 °C as the average of five
scans, using a five-second integration time at 1.0-nm wavelength
increments. Spectra were baseline-corrected against the cuvette with
buffer alone. Helix content was estimated from the CD signal by
dividing the mean residue ellipticity at 222 nm by the value expected
for 100% helix formation by helices of comparable size,
33,000
degrees cm2 dmol
1 (33). Thermal stability was
determined by monitoring the change in CD signal at 222 nm as a
function of temperature, and thermal melts were performed in 2-degree
intervals with a 2-min equilibration at the desired temperature and an
integration time of 30 s. The thermal melts were not reversible,
and the protein precipitated after thermal denaturation. The midpoint
of the thermal unfolding transition (apparent melting temperature,
Tm) was determined from the maximum of the first
derivative, with respect to the reciprocal of the temperature, of the
[
]222 values (34). The error in estimation of
Tm is ± 1 °C.
OG, loaded at initial concentrations
of 10, 40, and 150 µM, and analyzed at rotor speeds of 22 and 25 krpm at 20 °C. Data sets were fitted to a single-species
model. Protein partial specific volume and solvent density were
calculated with constants from Laue et al. (35). Molecular
weights were all within 10% of those calculated for an ideal trimer,
with no systematic deviation of the residuals.
OG. The
crystals were transferred to a cryoprotectant solution containing 25%
(v/v) glycerol in the corresponding mother liquor. Cryoprotected
crystals were frozen in propane before data collection. Data to 1.45 Å resolution were collected at 95 K using a Mar research 300 image plate
scanner at the X12B beamline of the National Synchrotron Light Source.
All diffraction intensities were integrated and scaled with the HKL
suite (36).
and
angles are in allowed regions of the
Ramachandran plot.
OG (correlation coefficient, 58.2%; R-factor, 43.8%). The model was subjected to rigid
body refinement (8.0-2.5 Å) of the whole molecule by using the
program X-PLOR (39). This procedure was followed by least squares
minimization of the atomic positions with the program O (38). The
resulting map was subjected to rounds of automatic tracing and model
building by using the program Arp-Warp 5.0 (40) and the program REFMAC from the CCP4 program suite (41). The refinement was monitored by using
the free R-factor. At this stage, the model yielded higher quality of the 2Fo
Fc and
Fo
Fc electron density maps
compared with the starting maps. Noncrystallograhic symmetry restraints
were not used in the refinement. Crystallographic refinement of the
structure was done with the program X-PLOR (39). The final refined
model (Rcryst = 20.0%;
Rfree = 24.5%) contains residues 548-578 and
628-651 of gp41, Gly-5 and Gly-6 of the linker, and 90 water
molecules. No ordered density was observed for
OG. Residues 546, 547, 579, and 652-655 of gp41 and Ser-1, Gly-2, Gly-3, and Arg-4 of
the linker are not seen in the electron density, and the side chains of
Gln-550 and Glu-647, as well as Met-629, are disordered and were thus
modeled as serine and alanine, respectively. All
and
angles are
within allowed regions. The atomic coordinates have been deposited in
the Protein Data Bank (codes 1DF4 and 1DF5).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helical structure, with characteristic double minima in CD spectra
at 222 and 208 nm (Fig. 2A).
Under these conditions, N34(L6)C28 exhibits a cooperative melt with an
apparent melting temperature (Tm) of 88 °C in 2 mM SDS, in contrast to that of 70 °C in aqueous buffer
(Fig. 2B; Table I).
Remarkably, N34(L6)C28 has a thermal stability that exceeds 100 °C
in 10 mM SDS micelles (Fig. 2B). Because
N34(L6)C28 denatures irreversibly with temperature in all cases,
Tm values measured by CD spectroscopy are useful as
only a qualitative guide to stability. Moreover, sedimentation
equilibrium measurements indicate that N34(L6)C28 sediments as a clean
trimer in 10 mM SDS micelles (Fig. 2C; Table
I).

View larger version (23K):
[in a new window]
Fig. 2.
Folding of N34(L6)C28 as a highly
thermostable, helical trimer in SDS micelles. A, CD
spectra at 20 °C in PBS (pH 7.0) and 10 µM protein
concentration without (squares) and with 2 mM
(triangles) and 10 mM (circles) SDS.
B, thermal melts monitored by CD at 222 nm in PBS (pH 7.0)
and 10 µM protein concentration without
(squares) and with 2 mM (triangles)
and 10 mM (circles) SDS. Inset shows
CD spectrum at 90 °C in 10 mM SDS micelles.
C, analytical ultracentrifugation data (22 krpm) collected
at 20 °C in PBS (pH 7.0) and ~10 µM protein
concentration in 10 mM SDS micelles. The natural logarithm
of the absorbance at 280 nm is plotted against the square of the radial
position. Deviations from the calculated values are plotted as
residuals (upper panel).
Summary of circular dichroism and sedimentation equilibrium data for
N34(L6)C28 in aqueous and membrane-mimetic media
OG micelles.
OG is a nonionic detergent with a critical micellar concentration of 25.3 mM. In PBS at a 10 µM
protein concentration in the presence of 35 mM
OG, CD
experiments indicate that the folded N34(L6)C28 molecule appears to be
~90% helical at 20 °C and ~45% helical at 90 °C (Fig.
3A; Table I). In addition,
sedimentation equilibrium experiments indicate that N34(L6)C28 is
trimeric in 35 mM
OG micelles (Fig. 3B; Table
I). Thus, N34(L6)C28 folds into a stable six-helix bundle structure in
OG micelles. These results strongly suggest that the fusion-active
gp41 core displays substantial affinity for detergents.

View larger version (27K):
[in a new window]
Fig. 3.
N34(L6)C28 forms a stable helical trimer
in
OG micelles. A, CD spectra
at 20 (triangles) and 90 °C (circles) in PBS
(pH 7.0) containing 35 mM
OG at 10 µM
protein concentration. B, analytical ultracentrifugation
data (22 krpm) collected at 20 °C in PBS (pH 7.0) and ~40
µM protein concentration in 35 mM
OG
micelles. The natural logarithm of the absorbance at 240 nm is plotted
against the square of the radial position. Deviations from the
calculated values are plotted as residuals (upper
panel).
-helical structures in both DMPG and POPE vesicles (Fig.
4). Because up to 2-fold reductions in
ellipticity have been observed in the spectra of membrane-bound
proteins (51, 52), it is striking that N34(L6)C28 appears to be more
helical in lipid environments than that in aqueous solution; the
ellipticities of N34(L6)C28 at 222 nm are 30,000, 34,000, and 39,000 degrees cm2/dmol in water, DMPG, and POPE, respectively
(Fig. 4). In the light of recent evidence that helix formation for
amino acids in lipid micelles/vesicles is qualitatively different from
that in water and that hydrophobic interactions between the side chain and lipid govern helix formation in membranes (47), the hydrophobic residues on the surface of the six-helix bundle appear to contribute to
the net extent of helix formation in lipid environments. In addition,
the CD spectra of N34(L6)C28 obtained in the DMPG and POPE vesicles
differ slightly from that in aqueous solution, probably due to the
stronger light-scattering effect of the phospholipid samples, which
produce higher noise levels during CD measurements.

View larger version (20K):
[in a new window]
Fig. 4.
Circular dichroism spectra of N34(L6)C28 at
20 °C and 10 µM protein
concentration in PBS (pH 7.0) without vesicles (open
circles) and with 4 mM DMPG (closed
circles) and 4 mM POPE (open
triangles) vesicles.
OG
micelles (see under "Experimental Procedures"). The rhombohedral crystals are isomorphous with those crystallized from aqueous solution.
The N34(L6)C28/
OG structure was refined to a conventional R-factor of 20.0% with a free R-factor of 24.5%
and root mean square deviations from ideal bond lengths and bond angles
of 0.017 Å and 2.0°, respectively (Table II). Representative
portions of the final 2Fo
Fc
maps with the refined molecular models superimposed are shown in Fig.
5. Details of the data collection and
refinement statistics are presented in Table II.
X-ray data collection and refinement statistics

View larger version (66K):
[in a new window]
Fig. 5.
Experimental electron density maps.
A, a portion of the final 2Fo
Fc map of N34(L6)C28/SDS with the refined molecular
model superimposed. B, a portion of the final
2Fo
Fc map of N34(L6)C28/
OG
with the refined molecular model superimposed. Water molecules are
indicated with small red balls. The maps are contoured at
1.5 S.D. above the mean density. Figure was generated with the program
O (38).
atoms of N34(L6)C28 in the aqueous
and detergent structures are 0.55 Å for SDS and 0.58 Å for
OG
(Fig. 6B). Thus, the N34(L6)C28 model of the gp41 core forms
extremely stable, well structured six-helix bundles in SDS and
OG
micellar media. However, the N and C termini of both the structures do
not have clear electron density and are presumed to be unfolded,
consistent with the lower helicity of the N34(L6)C28 molecule in
detergent micelles by CD measurements (Figs. 2 and 3).

View larger version (61K):
[in a new window]
Fig. 6.
Structures of the N34(L6)C28 trimer
crystallized in detergent micellar media. A, stereo
view from the top of the N34(L6)C28 trimer, along the
noncrystallographic 3-fold axis. The view is from the amino termini of
N34 and the carboxyl termini of C28. Helices in N34(L6)C28 from SDS
(green) and
OG (yellow) were used for the
superposition. B, stereo view of a N34(L6)C28 monomer from
the three structures. The
-carbon traces of the N34 and C28 helices
in the structures of water (62 residues) (red), SDS (62 residues) (green), and
OG (55 residues)
(white) were used for the superposition. The N terminus of
N34 and the C terminus of C28 are at the top of the figure.
Figure was generated with the program SETOR (56).
OG
molecules are not detected in the high resolution crystal structures of N34(L6)C28, probably because they do not often form ordered arrays due
to thermal motion (43, 44). It is also possible that the gp41 core
binds to lipid membranes through nonspecific interactions.

View larger version (52K):
[in a new window]
Fig. 7.
Stereo view of the superposition of residues
564-571 of N34 and 628-633 of C28 in the N34(L6)C28 structures in
water (red), SDS (green), and
OG (white), showing a
cross-section of helix packing near the conserved hydrophobic cavity in
the gp41 core. Figure was generated with the program SETOR
(56).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helical
coiled coil adjacent to the N-terminal fusion peptide that is known, at
least in the case of HA2, to insert into the host bilayer
at an initial step of membrane fusion (8, 9). Moreover, the polypeptide
chain reverses direction at the end of the N-terminal coiled coil and
forms an
-helix that proceeds toward the N terminus of the molecule.
The overall fusion mechanism of viral envelope proteins is thought to
involve the refolding of
-helical coiled coils that underlies
activation of membrane fusion (for a recent review, see Ref. 54). It is striking that this mechanism is likely to be shared by the SNARE proteins that mediate cellular membrane fusion processes (54).
OG micelles and
that the atomic structures of the gp41 core crystallized from detergent
micellar media are essentially the same as that in water. Our results
also indicate that the N34(L6)C28 model of the gp41 core can fold into
a fully helical conformation in DMPG and POPE bilayer vesicles. Taken together, these data do not support the kind of "spray and
insertion" model proposed on the basis of electron paramagnetic
resonance spectroscopic studies for apposing virus and cell membranes
(28). According to this model, the six-helix bundle splits apart and "melts" into lipid bilayers. Instead, our results support a fusion model in which the gp41 core causes close membrane apposition as the
six-helix complex is assembled for membrane fusion (20, 23, 27),
because this model predicts that the gp41 core binds to lipid
membranes. We propose that this membrane binding plays a critical role
in driving the gp41 conformational change during fusion activation and
may therefore be of fundamental importance in membrane apposition and
fusion. Understanding the determinants for the gp41 core-membrane
interaction is likely to provide insights into the basic property of
the conformational change that renders the gp41 molecule able to bind
to and alter the shape of the lipid bilayer.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of Biochemistry,
Weill Medical College of Cornell University, 1300 York Ave., New York,
NY 10021. Tel.: 212-746-6562; Fax: 212-746-8875; E-mail:
mlu@mail.med.cornell.edu.
![]()
ABBREVIATIONS
OG, n-octyl-
-D-glucopyranoside;
[
]222, molar ellipticity at 222 nm;
CD, circular
dichroism;
HPLC, high performance liquid chromatography;
Tm, midpoint of thermal denaturation;
PBS, neutral
pH phosphate-buffered saline;
DMPG, dimyristoylphosphatidylglycerol;
POPE, 1-palmitoyl, 1,2-oleyl phosphatidylcholine.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Carr, C. M.,
and Kim, P. S.
(1993)
Cell
73,
823-832[CrossRef][Medline]
[Order article via Infotrieve]
2.
Bullough, P. A.,
Hughson, F. M.,
Skehel, J. J.,
and Wiley, D. C.
(1994)
Nature
371,
37-43[CrossRef][Medline]
[Order article via Infotrieve]
3.
Chen, J.,
Wharton, S. A.,
Weissenhorn, W.,
Calder, L. J.,
Hughson, F. M.,
Skehel, J. J.,
and Wiley, D. C.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
12205-12209 4.
Carr, C. M.,
Chaudhry, C.,
and Kim, P. S.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14306-14313 5.
Wiley, D. C.,
and Skehel, J. J.
(1987)
Annu. Rev. Biochem.
56,
365-394[CrossRef][Medline]
[Order article via Infotrieve]
6.
Stegmann, T.,
and Helenius, A.
(1993)
in
Viral Fusion Mechanisms
(Bentz, J., ed)
, pp. 89-111, CRC Press, Boca Raton, FL
7.
Hernandez, L. D.,
Hoffman, L. R.,
Wolfsberg, T. G.,
and White, J. M.
(1996)
Annu. Rev. Cell Dev. Biol.
12,
627-661[CrossRef][Medline]
[Order article via Infotrieve]
8.
Stegmann, T.,
Delfino, J. M.,
Richards, F. M.,
and Helenius, A.
(1991)
J. Biol. Chem.
266,
18404-18410 9.
Tsurudome, M.,
Gluck, R.,
Graf, R.,
Falchetto, R.,
Schaller, U.,
and Brunner, J.
(1992)
J. Biol. Chem.
267,
20225-20232 10.
Luciw, P. A.
(1996)
in
Fields Virology
(Fields, B. N.
, Knipe, D. M.
, Howley, P. M.
, Chanock, R. M.
, Melinick, J. L.
, Monath, T. P.
, Roizman, B.
, and Straus, S. E., eds)
, pp. 1881-1952, Lippincott-Raven Publishers, Philadelphia
11.
Turner, B. G.,
and Summers, M. F.
(1998)
J. Mol. Biol.
285,
1-32
12.
Kwong, P. D.,
Wyatt, R.,
Robinson, J.,
Sweet, R. W.,
Sodroski, J.,
and Hendrickson, W. A.
(1998)
Nature
393,
648-659[CrossRef][Medline]
[Order article via Infotrieve]
13.
Rizzuto, C. D.,
Wyatt, R.,
Hernandez-Ramos, N.,
Sun, Y.,
Kwong, P. D.,
Hendrickson, W. A.,
and Sodroski, J.
(1998)
Science
280,
1949-1953 14.
Moore, J. P.,
Jameson, B. A.,
Weiss, R. A.,
and Sattentau, Q. J.
(1993)
in
Viral Fusion Mechanisms
(Bentz, J., ed)
, pp. 233-289, CRC Press, Boca Raton, FL
15.
Chan, D. C.,
and Kim, P. S.
(1998)
Cell
93,
681-684[CrossRef][Medline]
[Order article via Infotrieve]
16.
Lu, M.,
Blacklow, S. C.,
and Kim, P. S.
(1995)
Nat. Struct. Biol.
2,
1075-1082[CrossRef][Medline]
[Order article via Infotrieve]
17.
Lu, M.,
and Kim, P. S.
(1997)
J. Biomol. Struct. Dyn.
15,
465-471[Medline]
[Order article via Infotrieve]
18.
Lu, M.,
Ji, H.,
and Shen, S.
(1999)
J. Virol.
73,
4433-4438 19.
Chan, D. C.,
Fass, D.,
Berger, J. M.,
and Kim, P. S.
(1997)
Cell
89,
263-273[CrossRef][Medline]
[Order article via Infotrieve]
20.
Weissenhorn, W.,
Dessen, A.,
Harrison, S. C.,
Skehel, J. J.,
and Wiley, D. C.
(1997)
Nature
387,
426-430[CrossRef][Medline]
[Order article via Infotrieve]
21.
Tan, K.,
Liu, J.,
Wang, J.,
Shen, S.,
and Lu, M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
12303-12308 22.
Judice, J. K.,
Tom, J. Y. K.,
Huang, W.,
Wrin, T.,
Vennari, J.,
Petropoulos, C. J.,
and McDowell, R. S.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
13426-13430 23.
Furuta, R. A.,
Wild, C. T.,
Weng, Y.,
and Weiss, C. D.
(1998)
Nat. Struct. Biol.
5,
276-279[CrossRef][Medline]
[Order article via Infotrieve]
24.
Munoz-Barroso, I.,
Durell, S.,
Sakaguchi, K.,
Appella, E.,
and Blumenthal, R.
(1988)
J. Cell Biol.
140,
315-323 25.
Jiang, S.,
Lin, K.,
and Lu, M.
(1998)
J. Virol.
72,
10213-10217 26.
Fass, D.,
Harrison, S. C.,
and Kim, P. S.
(1997)
Nat. Struct. Biol.
3,
465-469
27.
Hughson, F. M.
(1997)
Curr. Biol.
7,
R565-R569[CrossRef][Medline]
[Order article via Infotrieve]
28.
Yu, Y. G.,
King, D. S.,
and Shin, Y.-K.
(1994)
Science
266,
274-276 29.
Rabenstein, M.,
and Shin, Y. K.
(1995)
Biochemistry
34,
13390-13397[CrossRef][Medline]
[Order article via Infotrieve]
30.
Studier, F. W.,
Rosenberg, A. H.,
Dunn, J. J.,
and Dubendorff, J. W.
(1990)
Methods Enzymol.
185,
60-89[Medline]
[Order article via Infotrieve]
31.
Edelhoch, H.
(1967)
Biochemistry
6,
1948-1954[CrossRef][Medline]
[Order article via Infotrieve]
32.
Shu, W.,
Ji, H.,
and Lu, M.
(1999)
Biochemistry
38,
5378-5385[CrossRef][Medline]
[Order article via Infotrieve]
33.
Chen, Y. H.,
Yang, J. T.,
and Chau, K. H.
(1974)
Biochemistry
13,
3350-3359[CrossRef][Medline]
[Order article via Infotrieve]
34.
Cantor, C.,
and Schimmel, P.
(1980)
Biophysical Chemistry, Part III
, pp. 1131-1132, W. H. Freeman Co., New York
35.
Laue, T. M.,
Shah, B. D.,
Ridgeway, T. M.,
and Pelletier, S. L.
(1992)
in
Analytical Ultracentrifugation in Biochemistry and Polymer Science
(Harding, S. E.
, Rowe, A. J.
, and Horton, J. C., eds)
, pp. 90-125, Royal Society of Chemistry, Cambridge, United Kingdom
36.
Otwinowski, Z.,
and Minor, W.
(1996)
Methods Enzymol.
276,
307-326
37.
Navaza, J.
(1994)
Acta Crystallogr. Sect. A
50,
157-163[CrossRef]
38.
Jones, T. A.,
Zou, J.-Y.,
and Cowan, S. W.
(1991)
Acta Crystallogr. Sect. A
47,
110-119
39.
Brünger, A. T.
(1992)
X-PLOR Version 3.1: A System for X-ray Crystallography and NMR
, Yale University Press, New Haven, CT
40.
Lamzin, V. S.,
and Wilson, K. S.
(1993)
Acta Crystallogr. Sect. D
49,
129-147[CrossRef][Medline]
[Order article via Infotrieve]
41.
CCP4.
(1994)
Acta Crystallogr. Sect. D
50,
760-763[CrossRef][Medline]
[Order article via Infotrieve]
42.
van de Ven, F. J. M.,
van Os, J. W.,
Wymenga, S. S.,
Remerowski, M. L.,
Konings, R. N.,
and Hibers, C. W.
(1993)
Biochemistry
32,
8322-8328[CrossRef][Medline]
[Order article via Infotrieve]
43.
Roth, M.,
Lewit-Bentley, A.,
Michel, H.,
Deisenhofer, J.,
Huber, R.,
and Oesterhelt, D.
(1989)
Nature
340,
659-662[CrossRef]
44.
Barber, J.
(1989)
Nature
340,
601[Medline]
[Order article via Infotrieve]
45.
Hoyt, D. W.,
and Gierasch, L. M.
(1991)
Biochemistry
30,
10155-10163[CrossRef][Medline]
[Order article via Infotrieve]
46.
Gordon, L. M.,
Curtain, C. C.,
Zhong, Y. C.,
Kirkpatrick, A.,
Mobley, P. W.,
and Waring, A. J.
(1992)
Biochim. Biophys. Acta
1139,
257-274[Medline]
[Order article via Infotrieve]
47.
Li, S. C.,
and Deber, C. M.
(1994)
Nat. Struct. Biol.
1,
368-373[CrossRef][Medline]
[Order article via Infotrieve]
48.
Rotering, B. V.,
Ohms, J. P.,
and Hagenmaier, H.
(1976)
Eur. J. Biochem.
70,
601-610[Medline]
[Order article via Infotrieve]
49.
Li, S.-C.,
and Deber, C. M.
(1993)
J. Biol. Chem.
268,
22975-22978 50.
Blumenthal, R.,
Henkart, M.,
and Steer, C. J.
(1983)
J. Biol. Chem.
258,
3409-3415 51.
Glaeser, R. M.,
and Jap, B. K.
(1985)
Biochemistry
24,
6398-6401[CrossRef][Medline]
[Order article via Infotrieve]
52.
Mao, D.,
and Wallace, B. A.
(1984)
Anal. Biochem.
142,
317-328[CrossRef][Medline]
[Order article via Infotrieve]
53.
Ji, H.,
Shu, W.,
Burling, F. T.,
Jiang, S.,
and Lu, M.
(1999)
J. Virol.
73,
8578-8586 54.
Skehel, J. J.,
and Wiley, D. C.
(1998)
Cell
95,
871-874[CrossRef][Medline]
[Order article via Infotrieve]
55.
Qiao, H.,
Pelletier, S. L.,
Hoffman, L.,
Hacker, J.,
Armstrong, R. T.,
and White, J. M.
(1998)
J. Cell Biol.
141,
1335-1347 56.
Evans, S. V.
(1993)
J. Mol. Graphics.
11,
134-138[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. He, S. Liu, J. Li, H. Lu, Z. Qi, Z. Liu, A. K. Debnath, and S. Jiang Conserved Salt Bridge between the N- and C-Terminal Heptad Repeat Regions of the Human Immunodeficiency Virus Type 1 gp41 Core Structure Is Critical for Virus Entry and Inhibition J. Virol., November 15, 2008; 82(22): 11129 - 11139. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Huang, Z. Qi, F. Wu, L. Kotula, S. Jiang, and Y.-H. Chen Interaction of HIV-1 gp41 Core with NPF Motif in Epsin: IMPLICATION IN ENDOCYTOSIS OF HIV J. Biol. Chem., May 30, 2008; 283(22): 14994 - 15002. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. He, Y. Xiao, H. Song, Q. Liang, D. Ju, X. Chen, H. Lu, W. Jing, S. Jiang, and L. Zhang Design and Evaluation of Sifuvirtide, a Novel HIV-1 Fusion Inhibitor J. Biol. Chem., April 25, 2008; 283(17): 11126 - 11134. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, W. Jing, B. Cheung, H. Lu, J. Sun, X. Yan, J. Niu, J. Farmar, S. Wu, and S. Jiang HIV gp41 C-terminal Heptad Repeat Contains Multifunctional Domains: RELATION TO MECHANISMS OF ACTION OF ANTI-HIV PEPTIDES J. Biol. Chem., March 30, 2007; 282(13): 9612 - 9620. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Huang, L. Lu, H. Lu, X. Chen, S. Jiang, and Y.-H. Chen Identification of the HIV-1 gp41 Core-binding Motif in the Scaffolding Domain of Caveolin-1 J. Biol. Chem., March 2, 2007; 282(9): 6143 - 6152. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu and M. Lu An Alanine-Zipper Structure Determined by Long Range Intermolecular Interactions J. Biol. Chem., December 6, 2002; 277(50): 48708 - 48713. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Joyce, W. M. Hurni, M. J. Bogusky, V. M. Garsky, X. Liang, M. P. Citron, R. C. Danzeisen, M. D. Miller, J. W. Shiver, and P. M. Keller Enhancement of alpha -Helicity in the HIV-1 Inhibitory Peptide DP178 Leads to an Increased Affinity for Human Monoclonal Antibody 2F5 but Does Not Elicit Neutralizing Responses in Vitro. IMPLICATIONS FOR VACCINE DESIGN J. Biol. Chem., November 22, 2002; 277(48): 45811 - 45820. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||